FASEB J. Integrated DNA Technologies
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-122804.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow All Versions of this Article:
fj.08-122804v1
fj.08-122804v2
23/4/1023    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Desmard, M.
Right arrow Articles by Boczkowski, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Desmard, M.
Right arrow Articles by Boczkowski, J.
(The FASEB Journal. 2009;23:1023-1031.)
© 2009 FASEB

A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia

Mathieu Desmard*,1, Kelly S. Davidge{ddagger}, Odile Bouvet{dagger}, Didier Morin§, Damien Roux{dagger}, Roberta Foresti**,{dagger}{dagger}, Jean D. Ricard{dagger},||, Erick Denamur{dagger}, Robert K. Poole{ddagger}, Philippe Montravers, Roberto Motterlini**,{dagger}{dagger} and Jorge Boczkowski*,#

* Inserm, U700, and

{dagger} Inserm, U722, Université Paris 7, Faculté de Médecine, Paris, France;

{ddagger} Department of Molecular Biology and Biotechnology, University of Sheffield, Western Bank, Sheffield, UK;

§ Inserm, U841 équipe 3, Université Paris 12, Faculté de Médecine, Creteil, France;

|| Réanimation Médicale, Assistance Publique–Hôpitaux de Paris, Hôpital Louis Mourier, Colombes, France;

Département Anesthésie-Réanimation Chirurgicale and

# Centre d’Investigation Clinique 07, Assistance Publique–Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Paris, France;

** Department of Surgical Research, Northwick Park Institute for Medical Research, Harrow, Middlesex, UK; and

{dagger}{dagger} Department of Drug Discovery and Development, Italian Institute of Technology, Genova, Italy

1Correspondence: Inserm U700, Faculté de Médecine Paris 7, site X. Bichat, BP416, 75870 Paris Cedex 18, France. E-mail: desmardmathieu{at}yahoo.fr

The search for new molecules to fight Pseudomonas aeruginosa is of paramount importance. Carbon monoxide (CO) is known to act as an effective inhibitor of the respiratory chain in P. aeruginosa, but the practical use of this gas as an antibacterial molecule is hampered by its toxicity and difficulty to manipulate. Here, we show that a water-soluble CO releaser (CORM-3) possesses bactericidal properties against laboratory and antibiotic-resistant P. aeruginosa. CORM-3 reduced the bacterial count by 4 logs 180 min after in vitro treatment. CORM-3-treated bacteria had a lower O2 consumption than vehicle-treated bacteria, and the decrease in O2 consumption temporally preceded the bactericidal action of CORM-3. These results support the hypothesis that the antimicrobial effect of CORM-3 is mediated by an interaction of CO liberated by the carrier with the bacterial respiratory chain. The antibacterial effect occurred at concentrations of CORM-3 that are 50-fold lower than toxic concentrations for eukaryotic cells. CORM-3 treatment compared to vehicle treatment decreased bacterial counts in the spleen and increased survival in immunocompetent and immunosuppressed mice following P. aeruginosa bacteremia. Our results suggest that CORMs could form the basis for developing a new therapeutic strategy against P. aeruginosa-induced infection.—Desmard, M., Davidge, K. S., Bouvet, O., Morin, D., Roux, D., Foresti, R., Ricard, J. D., Denamur, E., Poole, R. K., Montravers, P., Motterlini, R., Boczkowski, J. A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia.


Key Words: pharmacology • anti-infective agents • sepsis • microbiology




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. S. Davidge, G. Sanguinetti, C. H. Yee, A. G. Cox, C. W. McLeod, C. E. Monk, B. E. Mann, R. Motterlini, and R. K. Poole
Carbon Monoxide-releasing Antibacterial Molecules Target Respiration and Global Transcriptional Regulators
J. Biol. Chem., February 13, 2009; 284(7): 4516 - 4524.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.